4 results
Evaluation of the feasibility and reproducibility of Muscle Sound® in a morbid obese population.
The primary objective is to compare the OS in patients treated with IMCgp100 monotherapy versus Investigator*s Choice in HLA-A*0201 positive patients with advanced UM with no prior treatment in the metastatic setting. The secondary objectives of the…
To provide idelalisib, a marketed PI3K* inhibitor, in lieu of GS-9820, an investigational second generation PI3K* inhibitor, to subjects receiving GS-9820 in Study GS-US-315-0102 at the time of study closure.
Primary Objective: To assess which method for measuring muscle mass is most reliable compared to dual-energy X-ray absorptiometry (DEXA) scan in a population with class II/III obesity.Secondary Objectives:1. To assess which combination of methods…